Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Pharmaceutical Substances Syntheses, Patents, Applications - Part 179. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Raloxifene hydrochloride R 1781 1. AICIj CH2CI2 2. HjC SH 3. HCI THF Raloxifene hydrochloride VII VI 1. DMF 2. HjC SH AICIj CH2CI2 Raloxifene hydrochloride C0CI2 phosgene 6-methoxy-2- 4-methoxy-phenyl -benzo b thiophene-3-corbonyl chloride BCIj 1 2-dichloroethane 0 C -------------------- Roloxifene hydrochloride phenyl 2-piperidiho-ethyl ether hydrochloride alternative regiospecific synthesis of I deoxyanisoin 2-methyl- 2-propone-thiol DC tert-butyl 4 4 -di- methoxy-a-stilbenyl sulfide X 1782 R Raloxifene hydrochloride H-jC-CO-O-OH CHjCOOH toluene tert-butyl 4 4 -di- methoxy-a-stilbenyl sulfoxide XI Tos-OH. toluene Znl2 1 2-dichloroethane IX ------------------------ . zinc iodide tert-butyl 4-methoxyb enzyl sulfide XII I.BuLi THF p-onisoldehyde Reference s a b Jones C.D. et al. J. Med. Chem. JMCMAR 27 1057 1984 . EP 62 504 Lilly Co. appl. 1.4.1982 USA-prior. 3.4.1981 . Vicenzi J.T. et al. Org. Process Res. Dev. OPRDFK 3 56-59 1999 . a US 4 418 068 Lilly Co. 29.11.1983 USA-prior. 3.4.1981 . aa EP 699 672 E. Lilly Co. appl. 30.8.1995 USA-prior. 31.8.1994 . b EP 693 488 Lilly Co. appl. 20.7.1995 USA-prior. 22.7.1994 . US 4 380 635 Lilly Co. 19.4.1983 USA-prior. 3.4.1981 . c EP 738 725 E. Lilly Co. appl. 18.4.1996 USA-prior. 21.4.1995 . d WO 9 734 888 E. Lilly Co. appl. 20.3.1996 USA-prior. 19.3.1996 . e WO 9 640 691 E. Lilly Co. appl. 4.6.1996 USA-prior. 7.6.1995 . WO 9 640 693 E. Lilly Co. appl. 4.6.1996 USA-prior. 7.6.1995 . WO 9 640 677 E. Lilly Co. appl. 4.6.1996 USA-prior. 7.6.1995 . WO9 640 676 E. Lilly Co. appl. 4.6.1996 USA-prior. 7.6.1995 . US 5 512 701 E. Lilly Co. 30.4.1996 USA-prior. 7.6.1995 . preparation of an amorphous form and formulation WO 9 808 513 E. Lilly Co. appl. 22.8.1997 USA-prior. 28.8.1996 . preparation of glucopyranosides metabolites as antihyper libpidemics EP 683 170 E. Lilly Co. appl. 16.5.1995 USA-prior. 20.5.1994 . treatment of hormone dependent cancers EP 62 503 E. Lilly Co. appl. 1.4.1982 USA-prior. 3.4.1981 . method for lowering .
